Entrada Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.33

+0.26 (+3.68%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 2 14%

Sell 0 0%

Price Target

Analyst Price Target +146.1% upside

Low Target $12.20

Average Target $18.04

High Target $27.27

Current Price $7.33

Current
$7.33

Target
$18.04

$12.20 $18.04 avg $27.27

Scenario Analysis

Bear Case

$12.20

66.4%

Low target

Base Case

$18.04

+146.1%

Avg target

Bull Case

$27.27

+272.0%

High target

Risk/Reward

4.1x

Highly favorable

Price in Context

52-Week High

$16.45

-55.4% from high

52-Week Low

$4.93

+48.7% from low

Target vs 52W High

$18.04

+9.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%